FDA and industry support fixes to accelerated approval program
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesClinical TrialsComplianceNorth AmericaPharmaceuticalsProject managementQuality Assurance and ControlRegulatory Intelligence/Policy